Connection

SUE CRAWFORD to Animals

This is a "connection" page, showing publications SUE CRAWFORD has written about Animals.
Connection Strength

0.365
  1. COPII Vesicle Transport Is Required for Rotavirus NSP4 Interaction with the Autophagy Protein LC3 II and Trafficking to Viroplasms. J Virol. 2019 12 12; 94(1).
    View in: PubMed
    Score: 0.039
  2. Lipid droplets form complexes with viroplasms and are crucial for rotavirus replication. Curr Opin Virol. 2016 08; 19:11-5.
    View in: PubMed
    Score: 0.030
  3. Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies. Clin Vaccine Immunol. 2015 Feb; 22(2):168-77.
    View in: PubMed
    Score: 0.027
  4. Viroporin-mediated calcium-activated autophagy. Autophagy. 2013 May; 9(5):797-8.
    View in: PubMed
    Score: 0.024
  5. Autophagy hijacked through viroporin-activated calcium/calmodulin-dependent kinase kinase-? signaling is required for rotavirus replication. Proc Natl Acad Sci U S A. 2012 Dec 11; 109(50):E3405-13.
    View in: PubMed
    Score: 0.024
  6. Rotavirus viremia and extraintestinal viral infection in the neonatal rat model. J Virol. 2006 May; 80(10):4820-32.
    View in: PubMed
    Score: 0.015
  7. Insights into human norovirus cultivation in human intestinal enteroids. mSphere. 2024 Nov 21; 9(11):e0044824.
    View in: PubMed
    Score: 0.014
  8. Trypsin cleavage stabilizes the rotavirus VP4 spike. J Virol. 2001 Jul; 75(13):6052-61.
    View in: PubMed
    Score: 0.011
  9. A Genetically Engineered Rotavirus NSP2 Phosphorylation Mutant Impaired in Viroplasm Formation and Replication Shows an Early Interaction between vNSP2 and Cellular Lipid Droplets. J Virol. 2020 07 16; 94(15).
    View in: PubMed
    Score: 0.010
  10. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles. J Virol. 1999 Jun; 73(6):4813-22.
    View in: PubMed
    Score: 0.009
  11. Phosphorylation cascade regulates the formation and maturation of rotaviral replication factories. Proc Natl Acad Sci U S A. 2018 12 18; 115(51):E12015-E12023.
    View in: PubMed
    Score: 0.009
  12. A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection. Proc Natl Acad Sci U S A. 2017 01 24; 114(4):E570-E579.
    View in: PubMed
    Score: 0.008
  13. Viral infection. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18. Science. 2014 Nov 14; 346(6211):861-5.
    View in: PubMed
    Score: 0.007
  14. Plasmid-based human norovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNA. Proc Natl Acad Sci U S A. 2014 Sep 23; 111(38):E4043-52.
    View in: PubMed
    Score: 0.007
  15. Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J Virol. 1994 Sep; 68(9):5945-52.
    View in: PubMed
    Score: 0.007
  16. Structural basis of glycan interaction in gastroenteric viral pathogens. Curr Opin Virol. 2014 Aug; 7:119-27.
    View in: PubMed
    Score: 0.007
  17. A novel form of rotavirus NSP2 and phosphorylation-dependent NSP2-NSP5 interactions are associated with viroplasm assembly. J Virol. 2014 Jan; 88(2):786-98.
    View in: PubMed
    Score: 0.006
  18. Prevention of cholestasis in the murine rotavirus-induced biliary atresia model using passive immunization and nonreplicating virus-like particles. Vaccine. 2013 Nov 19; 31(48):5778-84.
    View in: PubMed
    Score: 0.006
  19. The VP8* domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans. J Virol. 2013 Jul; 87(13):7255-64.
    View in: PubMed
    Score: 0.006
  20. Secretory pathway antagonism by calicivirus homologues of Norwalk virus nonstructural protein p22 is restricted to noroviruses. Virol J. 2012 Sep 03; 9:181.
    View in: PubMed
    Score: 0.006
  21. Rotavirus non-structural proteins: structure and function. Curr Opin Virol. 2012 Aug; 2(4):380-8.
    View in: PubMed
    Score: 0.006
  22. Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature. 2012 Apr 15; 485(7397):256-9.
    View in: PubMed
    Score: 0.006
  23. Genetic divergence of rotavirus nonstructural protein 4 results in distinct serogroup-specific viroporin activity and intracellular punctate structure morphologies. J Virol. 2012 May; 86(9):4921-34.
    View in: PubMed
    Score: 0.006
  24. Osteopontin upregulation in rotavirus-induced murine biliary atresia requires replicating virus but is not necessary for development of biliary atresia. Virology. 2011 Sep 01; 417(2):281-92.
    View in: PubMed
    Score: 0.005
  25. Strain-dependent norovirus bioaccumulation in oysters. Appl Environ Microbiol. 2011 May; 77(10):3189-96.
    View in: PubMed
    Score: 0.005
  26. Rotavirus structural proteins and dsRNA are required for the human primary plasmacytoid dendritic cell IFNalpha response. PLoS Pathog. 2010 Jun 03; 6(6):e1000931.
    View in: PubMed
    Score: 0.005
  27. Rotavirus enterotoxin NSP4 has mucosal adjuvant properties. Vaccine. 2010 Apr 19; 28(18):3106-11.
    View in: PubMed
    Score: 0.005
  28. Integrins alpha1beta1 and alpha2beta1 are receptors for the rotavirus enterotoxin. Proc Natl Acad Sci U S A. 2008 Jul 01; 105(26):8811-8.
    View in: PubMed
    Score: 0.004
  29. Rotavirus infection enhances lipopolysaccharide-induced intussusception in a mouse model. J Virol. 2006 Dec; 80(24):12377-86.
    View in: PubMed
    Score: 0.004
  30. Replication and packaging of Norwalk virus RNA in cultured mammalian cells. Proc Natl Acad Sci U S A. 2005 Jul 19; 102(29):10327-32.
    View in: PubMed
    Score: 0.004
  31. The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation. J Virol. 2004 Jul; 78(13):6974-81.
    View in: PubMed
    Score: 0.003
  32. Production of serpins using baculovirus expression systems. Methods. 2004 Feb; 32(2):177-84.
    View in: PubMed
    Score: 0.003
  33. The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J Virol. 2003 Nov; 77(21):11603-15.
    View in: PubMed
    Score: 0.003
  34. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine. 2003 Sep 08; 21(25-26):3885-900.
    View in: PubMed
    Score: 0.003
  35. VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment. J Virol. 2002 Feb; 76(3):1109-23.
    View in: PubMed
    Score: 0.003
  36. Differential infection of polarized epithelial cell lines by sialic acid-dependent and sialic acid-independent rotavirus strains. J Virol. 2001 Dec; 75(23):11834-50.
    View in: PubMed
    Score: 0.003
  37. Pathogenesis of rotavirus gastroenteritis. Novartis Found Symp. 2001; 238:82-96; discussion 96-100.
    View in: PubMed
    Score: 0.003
  38. Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs. J Virol. 2000 Oct; 74(19):8843-53.
    View in: PubMed
    Score: 0.003
  39. Localization and quantification of glucose transporters in liver of growth-retarded fetal and neonatal rats. Am J Physiol. 1999 01; 276(1):E135-42.
    View in: PubMed
    Score: 0.002
  40. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity. J Virol. 1998 Nov; 72(11):9233-46.
    View in: PubMed
    Score: 0.002
  41. Interaction of platelet-activating factor, spleen and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in rats. J Physiol. 1998 Oct 01; 512 ( Pt 1):227-34.
    View in: PubMed
    Score: 0.002
  42. Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines. Vaccine. 1998 Mar; 16(5):507-16.
    View in: PubMed
    Score: 0.002
  43. Rotavirus virus-like particles administered mucosally induce protective immunity. J Virol. 1997 Nov; 71(11):8707-17.
    View in: PubMed
    Score: 0.002
  44. Virus-like particle vaccines for mucosal immunization. Adv Exp Med Biol. 1997; 412:387-95.
    View in: PubMed
    Score: 0.002
  45. Isotype-specific antibody responses to rotavirus and virus proteins in cows inoculated with subunit vaccines composed of recombinant SA11 rotavirus core-like particles (CLP) or virus-like particles (VLP). Vaccine. 1996 Oct; 14(14):1303-12.
    View in: PubMed
    Score: 0.002
  46. Rotavirus subunit vaccines. Arch Virol Suppl. 1996; 12:199-206.
    View in: PubMed
    Score: 0.002
  47. Rotavirus vaccine administered parenterally induces protective immunity. J Virol. 1993 Nov; 67(11):6633-41.
    View in: PubMed
    Score: 0.002
  48. Expression of rotavirus VP2 produces empty corelike particles. J Virol. 1991 Jun; 65(6):2946-52.
    View in: PubMed
    Score: 0.001
  49. Rotavirus SA11 genome segment 11 protein is a nonstructural phosphoprotein. J Virol. 1989 Sep; 63(9):3974-82.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.